RD HEALTHCARE LIMITED

Image description

PROVIDING A SERVICE FOR PHAMACEUTICAL AND MEDICAL DEVICES COMPANIES


PROVIDING CCG/GP/SURGERY/REPRESENTATIVES GEOGRAPHICAL BOUNDARIES PRESCRIPTION DATA ANALYSIS WITH NUMBER OF SCRIPTS, SALES AND NUMBER OF ITEMS PRESCRIBED EVERY MONTH/YEAR


SELLING PRODUCTS TO KOL'S IN THE CCG'S, PRIVATE, PRIMARY AND SECONDARY CARE MARKETS AT 1:1 AND PRESENTATION LEVEL

WORKING IN PHARMACEUTICAL AND MEDICAL DEVICES

WORKING ALONGSIDE COMPANIES AND TEAMS WITH DEVELOPING MARKET ACCESS

GP PRESCRIBING DATA ANALYSIS

The NHS has been challenged to make £20 billion in “efficiency savings” by 2010

£10 billion a year is spent by the NHS on essential drugs

Structural changes across the NHS means a dramatic impact on the sales process for pharmaceutical companies

With the Open Government Data initiative, official NHS FP10 sourced prescribing data has been released. Data accuracy to GP level is now guaranteed

The NHS data is vast, impenetrable and time consuming to extract

The answers are there. Prescribing success will go to those who can directe this data, use it and then deliver it TO winning sales strategies. 

This data analySIS can deliver the strategic insight necessary to gain the competitive edge over competitors in the market place

It needs enhancement and manipulation before it is suitable for analysis, making it impenetrable for the average user or sales team

RD Healthcare can now transform this NHS prescribing data into a rich source of primary care information to not only protect your own business but to target competitors

We can help target specific segments in therapy areas, look at HORC pricing strategies, and demonstrate cost savings based on accurate prescribing data down to GP practice or pharmacy level

Product managers, Business Units and Marketing can shape their market, plan their strategy and grow their brands via detailed market data insights

Companies can set realistic cost effective sales targets across CCG geographical boundaries

Market access and account managers can identify key accounts and customers, develop and implement their strategy, and monitor its effectiveness

Sales representatives are able to use regional and practice-level analysis to plan and implement their sales own strategy, as well as present cost effectiveness to key stakeholders

It is about getting what you need from the vast volumes of data available.

It takes a considerable amount of time, effort and resource to deliver the level of insight decision-makers that the sales teams need

RD Healthcare can deliver solutions that will help you drive sales

Image description

SELLING PRODUCTS TO CCG'S, PRIMARY AND SECONDARY CARE

RD Healthcare has a network of self employed consultants, many with over 25 years of expeience in the industry. We can offer a bespoke service to companies at a fraction of the cost of an employed sales-force. 

We have been partering companies to sell products at GP level to the new Commissioning Groups. Many of our consultants work two to three days a week using thier network of contacts to gain early success for companies whether it is sales or working to promote products with KOL's.

Why not use us to prmote a new product when your budgets are tight and need results?

Our network spans England, Wales, Scotland and Northern Ireland.

Image description

MARKET ACCESS

A pivotale role into today's NHS market for Companies!

Developing a market access call strategy can pay dividends.

If you’re not thinking about market access these days, you’re nowhere

The environment for the pricing and reimbursement of pharmaceuticals has become increasingly challenging

Regulation in these areas has tightened and across Europe a fourth hurdle – cost-effectiveness – has supplemented the established notions of safety, efficacy and manufacturing quality as a further requirement to secure market access

This shift has accelerated the emergence of a key group of influential stakeholders and provided the catalyst for an environment that is increasingly being controlled by payers

Achieving market access in the modern market is as much about understanding the needs of non-clinical stakeholders as it is about influencing the traditional, clinical decision-maker.

Developing an effective market access strategy requires a more customised and agile approach

There are four basic elements. Essentially, market access is about:

  • Considering the implications your product may have on the wider healthcare market
  • Understanding the impact the changing healthcare market will have on your product
  • Preparing a positive healthcare environment which supports uptake of your product
  • Communicating the ‘value’ of your product to the range of customers who influence uptake.

Meaning:

  • Strategically, market access is about packaging data in the right way, for the right customer at the right time.
  • In a changing NHS, aligning your product with a moving target is challenging and only by understanding the needs of all stakeholders involved in the adoption, positioning and funding of your product will you be able to develop messages that improve its chances of success.

RD Healtcare will "MAP IT"

We help you to know who your customers are and what their needs are.

  • Talk to them
  • Engage with them
  • Try to build a full understanding of their sphere of influence
  • How they are involved with certain processes and systems
  • How they are going to influence prescribing. 
Image description